Skip to main content
. 2016 Aug 17;11:199–209. doi: 10.1016/j.ebiom.2016.08.016

Fig. 5.

Fig. 5

Comparison of the prognostic accuracy of miRNA RS with IHC4 RS and 21-gene RS. (a) Kaplan-Meier survival curves for patients indifferent subgroups, which were stratified by IHC4 RS and miRNA RS. (b) Kaplan-Meier survival curves for the patients with intermediate-risk defined by IHC4 scoring. (c) Kaplan-Meier survival curves for patients stratified by 21-gene RS and the miRNA RS. 21-gene RS low risk, defined as a recurrence score < 18; 21-gene RS intermediate risk, defined as 18 ≤ score < 31; 21-gene RS high risk, defined as a score ≥ 31. (d) Kaplan-Meier survival curves for the patients with 21-gene RS intermediate risk stratified by miRNA RS. (e) Comparisons of the prognostic accuracy by miRNA RS (high vs. low risk), IHC4 RS and 21-gene RS. DRFS = distant relapse-free survival; RS = recurrence/risk score; and AUC = area under curve.